ASTEPRO 0.15%—the Earlier the Better
Compared with selected prescription antihistamines, ASTEPRO 0.15% offers the highest Tier 2 availability under commercial managed care plans*
- Eligible, insured patients who may need additional savings can use the Instant Savings Card to limit their prescription and refill copays to $25 through December 31, 2012
- ASTEPRO 0.15% is available without restriction on 93% of covered lives
e-Newsletter
Coming soon! Sign up for our healthcare professionals email series
View FAQs
See Frequently Asked Questions about ASTEPRO 0.15%
Comparison Chart
See a chart comparing ASTEPRO 0.15% and ASTEPRO 0.1%
Product Overview
View a product overview PDF for ASTEPRO 0.15%
Patanase is a registered trademark of Alcon, Inc. Clarinex is a registered trademark of the Schering Corporation.
*Data on file. Meda Pharmaceuticals Inc; June, 2011. Percentage based upon formulary coverage under commercial managed care organizations.
†For eligible, insured patients only. Coupon covers the balance of the copay over $25 (if any) for the first unit dispensed and for refills. Maximum value of $100 per dispensed unit.
Offer expires December 31, 2012. Please see full program terms and conditions on the back of the Instant Savings Card brochure or visit http://www.astepro.com/patients/termsandconditions.html.
Indication
ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.
Important Risk Information
- Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
- Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
- In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
- Pregnancy Category C: Based on animal data, may cause fetal harm
Please see full Prescribing Information
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088
